Showing results (81-90 of 113) with videos related to
Sort By:
Pageof 12
Current Oncology (Toronto, Ont.)|May 27, 2022
Identification of CT Values That Could Be Predictive of Necrosis (N-CTav) in Hepatocellular Carcinoma after Lenvatinib TreatmentMakoto Chuma, Hideki Yokoo, Atsushi Hiraoka, et al.JHEP Reports : Innovation in Hepatology|August 18, 2025
Restoration of the gut-microbiota-liver axis after hepatitis C virus eradicationTakako Inoue, Jiro Nakayama, Hiroshi Mori, et al.Journal of Gastroenterology and Hepatology|December 28, 2019
Analysis of factors associated with the prognosis of cirrhotic patients who were treated with tolvaptan for hepatic edemaMasanori Atsukawa, Akihito Tsubota, Koichi Takaguchi, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 22, 2022
Clinical outcomes of antithrombin III-based therapy for patients with portal vein thrombosis: A retrospective, multicenter studyKorenobu Hayama, Masanori Atsukawa, Akihito Tsubota, et al.Journal of Gastroenterology|May 10, 2018
Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in JapanHidenori Toyoda, Masanori Atsukawa, Koichi Takaguchi, et al.Hepatology International|December 8, 2022
Risk factors for portopulmonary hypertension in patients with cirrhosis: a prospective, multicenter studyMasanori Atsukawa, Akihito Tsubota, Chisa Kondo, et al.Hepatology (Baltimore, Md.)|March 11, 2021
Treatment and Renal Outcomes Up to 96 Weeks After Tenofovir Alafenamide Switch From Tenofovir Disoproxil Fumarate in Routine PracticeHidenori Toyoda, Jennifer Leong, Charles Landis, et al.Journal of Gastroenterology|May 10, 2024
ALBI score predicts morphological changes in esophageal varices following direct-acting antiviral-induced sustained virological response in patients with liver cirrhosisMasanori Atsukawa, Akihito Tsubota, Chisa Kondo, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 3, 2020
Analysis of efficacy of lenvatinib treatment in highly advanced hepatocellular carcinoma with tumor thrombus in the main trunk of the portal vein or tumor with more than 50% liver occupation: A multicenter analysisMakoto Chuma, Haruki Uojima, Atsushi Hiraoka, et al.Journal of Viral Hepatitis|June 3, 2022
International multicenter validation of GES score for HCC risk stratification in chronic hepatitis C patientsGamal Shiha, Reham Soliman, Nabiel N H Mikhail, et al.Pageof 12